Heart disease and stroke statistics—2022 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, A Alonso… - Circulation, 2022 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

[HTML][HTML] Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy

S Prasad, E Kalafat, H Blakeway, R Townsend… - Nature …, 2022 - nature.com
Safety and effectiveness of COVID-19 vaccines during pregnancy is a particular concern
affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 …

SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland

SJ Stock, J Carruthers, C Calvert, C Denny… - Nature medicine, 2022 - nature.com
Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …

2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association

SS Martin, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review

T Fiolet, Y Kherabi, CJ MacDonald, J Ghosn… - Clinical Microbiology …, 2022 - Elsevier
Background Vaccines are critical cost-effective tools to control the coronavirus disease 2019
(COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory …

[PDF][PDF] Living guidance for clinical management of COVID-19: living guidance, 23 November 2021

World Health Organization - 2021 - apps.who.int
This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …

The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis

SQ Wei, M Bilodeau-Bertrand, S Liu, N Auger - Cmaj, 2021 - Can Med Assoc
Background: The impact of coronavirus disease 2019 (COVID-19) on maternal and newborn
health is unclear. We aimed to evaluate the association between severe acute respiratory …

[PDF][PDF] COVID-19 clinical management: living guidance, 25 January 2021

(‎ 2021 World Health Organization - 2021 - apps.who.int
The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …

[HTML][HTML] Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States …

LD Zambrano - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed
SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 …